Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.

Kim JM, Stewart R, Lee YS, Lee HJ, Kim MC, Kim JW, Kang HJ, Bae KY, Kim SW, Shin IS, Hong YJ, Kim JH, Ahn Y, Jeong MH, Yoon JS.

JAMA. 2018 Jul 24;320(4):350-358. doi: 10.1001/jama.2018.9422.

PMID:
30043065
2.

Effectiveness of paroxetine in the treatment of poststroke depression.

Ma C, Li P.

Medicine (Baltimore). 2018 Jul;97(29):e11496. doi: 10.1097/MD.0000000000011496.

3.

An evaluation of the pharmacotherapy for interstitial cystitis.

Giusto LL, Zahner PM, Shoskes DA.

Expert Opin Pharmacother. 2018 Jul;19(10):1097-1108. doi: 10.1080/14656566.2018.1491968. Epub 2018 Jul 4. Review.

PMID:
29972328
4.

New Genetic Links to Depression May Pave the Way for Novel Treatment Strategies.

Hampton T.

JAMA. 2018 Jul 3;320(1):20-21. doi: 10.1001/jama.2017.12862. No abstract available.

PMID:
29971377
5.

Using sertraline in postpartum and breastfeeding: balancing risks and benefits.

Cuomo A, Maina G, Neal SM, De Montis G, Rosso G, Scheggi S, Beccarini Crescenzi B, Bolognesi S, Goracci A, Coluccia A, Ferretti F, Fagiolini A.

Expert Opin Drug Saf. 2018 Jul;17(7):719-725. doi: 10.1080/14740338.2018.1491546. Epub 2018 Jul 5. Review.

PMID:
29927667
6.

Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials.

Raupp-Barcaro IF, Vital MA, Galduróz JC, Andreatini R.

Rev Bras Psiquiatr. 2018 Oct-Dec;40(4):449-458. doi: 10.1590/1516-4446-2017-2393. Epub 2018 Jun 11. Review.

7.

Mirtazapine adjunct for people with schizophrenia.

Perry LA, Ramson D, Stricklin S.

Cochrane Database Syst Rev. 2018 May 26;5:CD011943. doi: 10.1002/14651858.CD011943.pub2. Review.

PMID:
29802811
8.

Antidepressants for insomnia in adults.

Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CC, Wilson S.

Cochrane Database Syst Rev. 2018 May 14;5:CD010753. doi: 10.1002/14651858.CD010753.pub2. Review.

PMID:
29761479
9.

Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis.

Qin B, Chen H, Gao W, Zhao LB, Zhao MJ, Qin HX, Chen W, Chen L, Yang MX.

Braz J Med Biol Res. 2018;51(7):e7218. doi: 10.1590/1414-431x20187218. Epub 2018 May 7. Review.

10.

Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.

Agabio R, Trogu E, Pani PP.

Cochrane Database Syst Rev. 2018 Apr 24;4:CD008581. doi: 10.1002/14651858.CD008581.pub2. Review.

PMID:
29688573
11.

Antidepressants for the treatment of depression in people with cancer.

Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2018 Apr 23;4:CD011006. doi: 10.1002/14651858.CD011006.pub3. Review.

PMID:
29683474
12.

Mirtazapine.

Al-Majed A, Bakheit AH, Alharbi RM, Abdel Aziz HA.

Profiles Drug Subst Excip Relat Methodol. 2018;43:209-254. doi: 10.1016/bs.podrm.2018.01.002. Epub 2018 Mar 30. Review.

PMID:
29678261
14.

Antidepressants for preventing postnatal depression.

Molyneaux E, Telesia LA, Henshaw C, Boath E, Bradley E, Howard LM.

Cochrane Database Syst Rev. 2018 Apr 18;4:CD004363. doi: 10.1002/14651858.CD004363.pub3. Review.

PMID:
29669175
15.

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.

Durgam S, Chen C, Migliore R, Prakash C, Edwards J, Findling RL.

Paediatr Drugs. 2018 Aug;20(4):353-363. doi: 10.1007/s40272-018-0290-4.

16.

Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder.

Ragguett RM, Rong C, Rosenblat JD, Ho RC, McIntyre RS.

Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):475-482. doi: 10.1080/17425255.2018.1459564. Epub 2018 Apr 6. Review.

PMID:
29621905
17.

Antidepressants versus placebo for panic disorder in adults.

Bighelli I, Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G, Furukawa TA, Barbui C.

Cochrane Database Syst Rev. 2018 Apr 5;4:CD010676. doi: 10.1002/14651858.CD010676.pub2. Review.

PMID:
29620793
18.
19.

Efficacy of escitalopram oxalate for patients with post-stroke depression.

Xu JH, Jiang P.

Medicine (Baltimore). 2018 Apr;97(14):e0219. doi: 10.1097/MD.0000000000010219.

20.

Personalized (N-of-1) Trials for Depression: A Systematic Review.

Kronish IM, Hampsey M, Falzon L, Konrad B, Davidson KW.

J Clin Psychopharmacol. 2018 Jun;38(3):218-225. doi: 10.1097/JCP.0000000000000864. Review.

PMID:
29596148

Supplemental Content

Loading ...
Support Center